XML 124 R89.htm IDEA: XBRL DOCUMENT v3.21.1
Share-based payments - 2020 grant to new CEO and supervisory board grant (Details) - 2019 Plan
€ / shares in Units, € in Thousands, SFr in Thousands
4 Months Ended 12 Months Ended
Dec. 18, 2020
Options
€ / shares
Dec. 01, 2020
CHF (SFr)
USD ($)
Dec. 01, 2020
$ / shares
Sep. 11, 2020
Options
USD ($)
Apr. 15, 2021
Options
USD ($)
$ / shares
Dec. 31, 2020
CHF (SFr)
Options
USD ($)
Dec. 31, 2020
Options
USD ($)
$ / shares
shares
Dec. 31, 2020
EUR (€)
Options
USD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year           1,585,100   1,585,100
Number                
Outstanding at January 1 | Options         154,925      
Granted during the year | Options           154,925   154,925
Outstanding at December 31 | Options           154,925   154,925
Vested at December 31 | shares             36,175  
Exercisable at December 31 | Options             36,175  
WAEP                
Outstanding at January 1 | $ / shares         $ 11.60      
Granted during the year | (per share) € 0           $ 11.60  
Outstanding at December 31 | $ / shares             11.60  
Vested at December 31 | $ / shares             11.60  
Exercisable at December 31 | $ / shares             $ 11.60  
Number                
Outstanding as of January 1         1,585,100      
Granted during the year           1,585,100   1,585,100
Outstanding as of December 31           1,585,100   1,585,100
Vested at December 31           124,850   124,850
Exercisable as of December 31             124,850  
RSUs                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year | Options 300,000              
Contractual life 10 years              
Number                
Granted during the year | Options 300,000              
Chief Executive Officer                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year | Options           1,033,600   1,033,600
Value of ordinary shares to be issued as per share based payment arrangement | SFr   SFr 1,000            
Value of other equity instruments granted under share based payment arrangement | SFr   SFr 1,400       SFr 1,400    
Contractual life   10 years            
Number                
Granted during the year | Options           154,925   154,925
Number                
Granted during the year | Options           1,033,600   1,033,600
Chief Executive Officer | RSUs                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year   324,000   72,350        
Number                
Granted during the year   324,000   72,350        
Chief Executive Officer | Performance Based RSUs                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year   500,000            
Number                
Granted during the year   500,000            
Chief Executive Officer | Options                
Number                
Granted during the year | Options       36,175        
Chief Executive Officer | Volume weighted average stock price equals or exceeds USD 24 prior to January 1st, 2023                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Number of units vested during the period   200,000            
Share hurdle price | $ / shares     $ 24          
Chief Executive Officer | Volume weighted average stock price equals or exceeds USD 33 prior to January 1st, 2024.                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Number of units vested during the period   300,000            
Share hurdle price | $ / shares     $ 33          
Supervisory board members                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Granted during the year           300,000   300,000
Contractual life           10 years   10 years
Value of equity ordinary shares | €               € 80,000
Maximum percentage of lost time injury           100.00%   100.00%
Period of tradings days           60 days   60 days
Number                
Granted during the year           300,000   300,000
Supervisory board members | RSUs                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Percentage of award constitutes RSU's           75.00%   75.00%
Supervisory board members | Options                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Percentage of award constitutes stock options           25.00%   25.00%
Chairman                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Value of additional equity ordinary shares | €               € 60,000
Vice chairman                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Value of additional equity ordinary shares | €               40,000
Chairman of audit committee                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Value of additional equity ordinary shares | €               40,000
Chairman of compensation committee                
Disclosure of terms and conditions of share-based payment arrangement [line items]                
Value of additional equity ordinary shares | €               € 8,000